Resultados de procura - Dirk Hasenclever

Limitar resultados
  1. 1
    Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease

    Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease por Dirk Hasenclever, Markus Loeffler, Volker Diehl

    Publicado 1996
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Should Treatment of Hepatitis B Depend on Hepatitis B virus Genotypes? A Hypothesis Generated from an Explorative Analysis of Published Evidence

    Should Treatment of Hepatitis B Depend on Hepatitis B virus Genotypes? A Hypothesis Generated from an Explorative Analysis of Published Evidence por Johannes Wiegand, Dirk Hasenclever, Hans L. Tillmann

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20<sup>+</sup>B-Cell Lymphoma in the Rituximab Era

    Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20<sup>+</sup>B-Cell Lymphoma in the Rituximab Era por Marita Ziepert, Dirk Hasenclever, Evelyn Kuhnt, Bertram Glaß, Norbert Schmitz, Michael Pfreundschuh, Markus Loeffler

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery)

    Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery) por Carina Benstoem, Christian Stoppe, Oliver J. Liakopoulos, Julia Ney, Dirk Hasenclever, Patrick Meybohm, Andreas Goetzenich

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease

    Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease por Angela Gause, Christoph Pohl, Astrid Tschiersch, L. Da Costa, W. Jung, Volker Diehl, Dirk Hasenclever, Michael Pfreundschuh

    Publicado 1991
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial

    Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogas... por Ulrich Hacker, Dirk Hasenclever, R. Baber, Nicolas Linder, Harald Busse, Radka Obermannová, Lenka Zdražilová Dubská, Dalibor Valík, Florian Lordick

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

    Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial por Ulrich Hacker, Dirk Hasenclever, Nicolas Linder, Gertraud Stocker, Hyun Cheol Chung, Yoon‐Koo Kang, Markus Moehler, Harald Busse, Florian Lordick

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

    BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease por Volker Diehl, M. Sieber, U. Rüffer, B. Lathan, Dirk Hasenclever, Michael Pfreundschuh, Markus Loeffler, D. Lieberz, P. Koch, Michael Adler, Hans Tesch

    Publicado 1997
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease

    Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgk... por Volker Diehl, Markus Loeffler, Michael Pfreundschuh, U. Ruehl, Dirk Hasenclever, Hiltrud Nisters-Backes, M. Sieber, Kirby L. Smith, Hans Tesch, Wilhelm Geilen

    Publicado 1995
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

    Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease por Volker Diehl, Jeremy Franklin, Michael Pfreundschuh, B. Lathan, Ursula Paulus, Dirk Hasenclever, Hans Tesch, Richard Herrmann, Bernd Dörken, Hans–Konrad Müller–Hermelink, E. Dühmke, Markus Loeffler

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Resection alone in 58 children with limited stage, lymphocyte‐predominant Hodgkin lymphoma–experience from the European network group on pediatric Hodgkin lymphoma

    Resection alone in 58 children with limited stage, lymphocyte‐predominant Hodgkin lymphoma–experience from the European network group on pediatric Hodgkin lymphoma por Christine Mauz‐Körholz, S. Gorde-Grosjean, Dirk Hasenclever, Ananth Shankar, W Dörffel, William H. Wallace, G. Schellong, Alain Robert, Dieter Körholz, Odile Oberlin, Georgina Hall, Judith Landman‐Parker

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

    Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma por Wolfram Klapper, Markus Kreuz, Christian Köhler, Birgit Burkhardt, Monika Szczepanowski, Itziar Salaverría, Michael Hummel, Markus Loeffler, Shoji Pellissery, Wilhelm Woessmann, Carsten Schwänen, Lorenz Trümper, Swen Weßendorf, Rainer Spang, Dirk Hasenclever, Reiner Siebert

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Antibodies in the Diagnosis of Coeliac Disease: A Biopsy-Controlled, International, Multicentre Study of 376 Children with Coeliac Disease and 695 Controls

    Antibodies in the Diagnosis of Coeliac Disease: A Biopsy-Controlled, International, Multicentre Study of 376 Children with Coeliac Disease and 695 Controls por Johannes Wolf, Dirk Hasenclever, David Petroff, Thomas Richter, Holm H. Uhlig, Martin W. Laaβ, Almuthe Hauer, Martin Stern, Xavier Bossuyt, Jan de Laffolie, Gunter Flemming, Danilo Villalta, Wolfgang Schlumberger, Thomas Mothes

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group

    Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet... por Stephen Daw, Dirk Hasenclever, Maurizio Mascarin, Ana Fernández‐Teijeiro, Walentyna Balwierz, Auke Beishuizen, Roberta Burnelli, Michaela Čepelová, Alexander Claviez, Karin Dieckmann, Judith Landman‐Parker, Regine Kluge, Dieter Körholz, Christine Mauz‐Körholz, William H. Wallace, Thierry Leblanc

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

    Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer por Marcus Schmidt, Dirk Hasenclever, Mitra Schaeffer, Daniel Boehm, Cristina Cotarelo, Eric Steiner, Antje Lebrecht, Wulf Siggelkow, W. Weikel, Ilka Schiffer-Petry, Susanne Gebhard, Henryk Pilch, Mathias Gehrmann, Hans‐Anton Lehr, Heinz Koelbl, Jan G. Hengstler, Martin Schüler

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy

    Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy por Johannes Wolf, David Petroff, Thomas Richter, Marcus Auth, Holm H. Uhlig, Martin W. Laaß, Peter Lauenstein, Andreas Krahl, Norman Händel, Jan de Laffolie, Almuthe Hauer, Thomas Kehler, Gunter Flemming, Frank P. Schmidt, Astor Rodrigues, Dirk Hasenclever, Thomas Mothes

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study

    Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study por Christine Mauz‐Körholz, Dirk Hasenclever, W Dörffel, Kathrin Ruschke, Tanja Pelz, Antje Voigt, Martina Stiefel, Melanie Winkler, Constanze Vilser, Karin Dieckmann, Jonas Karlén, Eva Bergsträßer, Alexander Fosså, Georg Mann, Michael Hummel, Wolfram Klapper, Harald Stein, Dirk Vordermark, Regine Kluge, Dieter Körholz

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

    Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study por Andreas Engert, Volker Diehl, Jeremy Franklin, Andreas Lohri, Bernd Dörken, Wolf‐Dieter Ludwig, P. Koch, Mathias Hänel, Michael Pfreundschuh, Martin Wilhelm, Lorenz Trümper, Walter-Erich Aulitzky, Martin Bentz, Mathias Rummel, Orhan Sezer, Hans–Konrad Müller–Hermelink, Dirk Hasenclever, Markus Löffler

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma

    Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma por Regine Kluge, Lidia Chavdarova, Martha Hoffmann, Carsten Kobe, Bogdan Małkowski, Françoise Montravers, Lars Kurch, Thomas Georgi, Markus Dietlein, William H. Wallace, Jonas Karlén, Ana Fernández‐Teijeiro, Michaela Čepelová, L Wilson, Eva Bergstraesser, Osama Sabri, Christine Mauz‐Körholz, Dieter Körholz, Dirk Hasenclever

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma

    [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma por Sandra Purz, Christine Mauz‐Körholz, Dieter Körholz, Dirk Hasenclever, Annaliese Krausse, Ina Sorge, Kathrin Ruschke, Martina Stiefel, Holger Amthauer, Otmar Schober, W. T. Kranert, Wolfgang Weber, Uwe Haberkorn, Patrick Hundsdörfer, Karoline Ehlert, Martina Becker, Jochen Rößler, Andreas E. Kulozik, Osama Sabri, Regine Kluge

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: